[HTML][HTML] PPARα deficiency in inflammatory cells suppresses tumor growth

A Kaipainen, MW Kieran, S Huang, C Butterfield… - PloS one, 2007 - journals.plos.org
A Kaipainen, MW Kieran, S Huang, C Butterfield, D Bielenberg, G Mostoslavsky, R Mulligan…
PloS one, 2007journals.plos.org
Inflammation in the tumor bed can either promote or inhibit tumor growth. Peroxisome
proliferator-activated receptor (PPAR) α is a central transcriptional suppressor of
inflammation, and may therefore modulate tumor growth. Here we show that PPARα
deficiency in the host leads to overt inflammation that suppresses angiogenesis via excess
production of the endogenous angiogenesis inhibitor thrombospondin-1 and prevents tumor
growth. Bone marrow transplantation and granulocyte depletion show that PPARα …
Inflammation in the tumor bed can either promote or inhibit tumor growth. Peroxisome proliferator-activated receptor (PPAR)α is a central transcriptional suppressor of inflammation, and may therefore modulate tumor growth. Here we show that PPARα deficiency in the host leads to overt inflammation that suppresses angiogenesis via excess production of the endogenous angiogenesis inhibitor thrombospondin-1 and prevents tumor growth. Bone marrow transplantation and granulocyte depletion show that PPARα expressing granulocytes are necessary for tumor growth. Neutralization of thrombospondin-1 restores tumor growth in PPARα-deficient mice. These findings suggest that the absence of PPARα activity renders inflammatory infiltrates tumor suppressive and, thus, may provide a target for inhibiting tumor growth by modulating stromal processes, such as angiogenesis.
PLOS